Ownership history in Qube Research & Technologies Ltd · 10 quarters on record
This page tracks every 13F SEC filing in which Qube Research & Technologies Ltd reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 65,226 | -50,175 | -43.5% | 0.00% | $57K | $8.70 |
| 2025 Q2 | ADDED | 115,401 | +46,503 | +67.5% | 0.00% | $82K | $7.10 |
| 2024 Q3 | REDUCED | 68,898 | -1,716 | -2.4% | 0.00% | $238K | $34.60 |
| 2024 Q2 | ADDED | 70,614 | +65,661 | +1325.7% | 0.00% | $207K | $29.30 |
| 2023 Q3 | REDUCED | 4,953 | -34,679 | -87.5% | 0.00% | $17K | $34.70 |
| 2023 Q1 | ADDED | 39,632 | +10,334 | +35.3% | 0.00% | $183K | $46.20 |
| 2022 Q2 | ADDED | 29,298 | +19,206 | +190.3% | 0.00% | $153K | $52.10 |
| 2021 Q4 | REDUCED | 10,092 | -5,247 | -34.2% | 0.00% | $150K | $148.80 |
| 2021 Q2 | ADDED | 15,339 | +3,892 | +34.0% | 0.00% | $285K | $185.90 |
| 2021 Q1 | INITIATED | 11,447 | — | — | 0.00% | $261K | $227.60 |
As of 2025 Q4 — sorted by position size